Clinical Trial Update: Chemotherapy With or Without Enoxaparin in Pancreatic Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating chemotherapy with versus without enoxaparin in pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: CONKO-Studiengruppe | Conditions: Pancreatic Cancer | Phase 2, Phase 3 | Status: COMPLETED